Article Information
History
- April 3, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ed M. Dicks1,
- Jonthan P. Tyrer1,
- Suzana Ezquina1,
- Michelle Jones2,
- John Baierl3,
- Pei-Chen Peng3,
- Michael Diaz2,
- Ellen Goode4,
- Stacey J Winham4,
- Thilo Dörk5,
- Toon Van Gorp6,
- Ana De Fazio7,8,9,
- David Bowtell10,
- Kunle Odunsi11,
- Kirsten Moysich12,
- Marina Pavanello13,14,
- Ian Campbell15,
- James D. Brenton16,
- Susan J. Ramus13,17,
- Simon A. Gayther2 and
- Paul D. P. Pharoah3,*
- 1Department of Public Health and Primary Care, University of Cambridge, UK
- 2Department of Biomedical Sciences, Cedars-Sinai Medical Centre, Los Angeles, USA
- 3Department of Computational Biomedicine, Cedars-Sinai Medical Centre, Los Angeles, USA
- 4Mayo Clinic, Rochester, MN, USA
- 5Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
- 6Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
- 7Centre for Cancer Research, The Westmead Institute for Medical Research, Westmead Hospital, Sydney, New South Wales, Australia
- 8The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Westmead Hospital, Sydney, New South Wales, Australia
- 9Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
- 10Cancer Genomics and Genetics and Women’s Cancer Programs, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- 11University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA
- 12Division of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
- 13School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW, Australia
- 14Center for Research in Immuno-Oncology, Albert Einstein Israelite Hospital, São Paulo, SP, Brazil
- 15Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
- 16Department of Oncology, University of Cambridge, UK
- 17Adult Cancer Program, Lowy Cancer Research Centre, University of NSW, Sydney, NSW, Australia
- ↵*Correspondence to Paul Pharoah, paul.pharoah{at}cshs.org
Posted April 03, 2024.
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
